TREACE JOHN T. (Chief Executive Officer) purchased 0.8% of their position (55.94K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $246.7K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/24/2026ACC: 0001193125-26-363737
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+55.94K
Net shares
Net buyer
$246.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
55.94K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+39.94K
Price / share
$4.44
Trade value
$177.18K
% of position
0.5%
8/20/2026
7.35M→7.39M
Common Stock
Direct
Shares
+5K
Price / share
$4.35
Trade value
$21.75K
% of position
0.1%
8/21/2026
7.39M→7.39M
Common Stock
Direct
Shares
+11K
Price / share
$4.34
Trade value
$47.73K
% of position
0.1%
8/24/2026
7.39M→7.40M
Total
Net shares
+55.94K
Net value
$246.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2026 | P · Purchase | +39.94K | $4.44 | $177.18K | 0.5% | 7.35M | 7.39M |
| Common Stock Direct | 8/21/2026 | P · Purchase | +5K | $4.35 | $21.75K | 0.1% | 7.39M | 7.39M |
| Common Stock Direct | 8/24/2026 | P · Purchase | +11K | $4.34 | $47.73K | 0.1% | 7.39M | 7.40M |
| Total | +55.94K | $246.65K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.60M
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned1.47M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.60M | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 1.47M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported